Navigation Links
Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
Date:11/6/2012

CRANBURY, N.J. and CAMBRIDGE, Mass., Nov. 6, 2012 /PRNewswire/ -- Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture, and commercialize four of Oncobiologics' biosimilar therapies for cancer and immunological disease in the Middle East and North African (MENA) regions.

Under the agreement, Boston Oncology—a pharmaceutical company that localizes advanced technologies and manufacturing expertise in the developing world—will provide Oncobiologics with upfront licensing payments and development milestone payments, along with royalties after the medicines are commercialized. Boston Oncology plans to oversee clinical trials and the development of manufacturing facilities for these therapies in various MENA markets.

The four biosimilars under agreement are generic versions of the most popular therapies in the world for their indications, representing annual global revenue of more than $25 billion.

"This partnership represents a critical step in Boston Oncology's mission to provide people in emerging nations with cost-effective, locally-produced therapeutics for cancers and inflammatory diseases," said Boston Oncology Founder and CEO Abdullah Baaj, M.D., Pharm. D. "Oncobiologics has a rigorous R&D program that will allow us to bring biosimilar therapies to the Middle East and North Africa."

"We are thrilled to announce this strategic alliance with Boston Oncology, which represents the perfect partner for launching Oncobiologics' first four biosimilar molecules in the MENA region," said Pankaj Mohan, Ph.D., CEO of Oncobiologics. "Boston Oncology has built an innovative, forward-looking model that will bring affordable, therapeutically important medicines to emerging markets," he said.

Specific financial terms were not disclosed. 

About Oncobiologics, Inc.
Oncobiologics is a biopharmaceutical company developing a pipeline of biosimilars and next generation biotherapeutics focused on clinically validated targets in the therapeutic areas of oncology, immuno-oncology, and immunology. Formed by a team of leading industry experts, Oncobiologics operates from a state-of-the-art R&D facility in Cranbury, NJ. Together with its biosimilars licensing partner, Parilis Biopharmaceuticals, Oncobiologics is actively pursuing commercial partner­ship opportunities. For more information, please visit www.oncobiologics.com or call 609-619-3990.

About Boston Oncology, LLC
Boston Oncology, LLC is a privately held company headquartered in Cambridge, Massachusetts, USA. Registered in 2012, Boston Oncology acquires, manages, and transfers intellectual property to locally produce generic chemotherapy and biologic pharmaceuticals in developing nations and emerging markets across the world. Visit www.bostononcology.com. Contact:ONCOBIOLOGICS, INC.BUSINESS & TECHNICAL INQUIRIESStephen J. McAndrew, Ph.D.609-619-3990, ext. 216stephenmcandrew@oncobiologics.com MEDIA INQUIRIESRick Gregory860-677-2377rickgregory@oncobiologics.comBOSTON ONCOLOGY, LLCBUSINESS INQUIRIESZeshawn Beg, DBA, CMACFO, Boston Oncology, LLC617-800-9439zbeg@bostononcology.com MEDIA INQUIRIESSarah Welch DeMayoVibrancy Communications781-727-7516sarah@vibrancycom.com This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Oncobiologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael F. Mahoney Assumes Role of Chief Executive Officer and President of Boston Scientific
2. Varian Medical Systems to Proceed with Year End Review and Webcast for Investors at ASTRO Meeting in Boston
3. Boston Scientific to Acquire BridgePoint Medical, Inc.
4. MD+DI Announces Wireless Connectivity in Medical Devices EAST Conference in Boston, MA
5. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
6. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2012 In Boston On September 5, 2012
7. Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
8. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
9. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
10. Boston Scientific to Announce Second-Quarter 2012 Financial Results on July 26
11. Last Chance to Save on Boston-Area Mobile Health, Biotech, and Pharmaceutical Conference Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... May 18, 2017  Two Bayer U.S. Pharmaceutical leaders ... during its recent 28 th Woman of ... event showcases HBA,s longstanding mission of furthering the advancement ... Cindy Powell-Steffen , senior director of ... division, and Libby Howe , a regional business ...
(Date:5/12/2017)... 12, 2017  The China and Canada ... consumes less water, energy and detergent, and features a powerful disinfection ... a shoebox-sized washing machine that washes and sanitizes women,s panties or ... ... compact, and does not require an external water inlet. ...
(Date:5/10/2017)... WASHINGTON , May 10, 2017  The ... doctors or employees of sleep therapy clinics to ... a sleep therapy clinic is involved in a ... as interested in hearing from an employee of ... involved in a kickback scheme to provide medical practice ...
Breaking Medicine Technology:
(Date:5/28/2017)... ... 2017 , ... Starting in May, patients at The Bay Clinic of ... diagnostic test. , Nerve-Express, originally designed for the Navy in the 1980s, measures the ... patient’s autonomic nervous system (ANS). The ANS controls all the critical unconscious functions ...
(Date:5/28/2017)... Winter Haven, FL (PRWEB) , ... May 28, ... ... Physician Partners of America (PPOA), is proud to announce that Sheldon K. Cho, ... on comprehensive interventional pain management, a specialty that concentrates on minimally invasive techniques ...
(Date:5/27/2017)... ... May 27, 2017 , ... Hate visiting the dentist? You should go twice per year ... care of your teeth at home. Here are some dental tips to help out: , ... small toothbrush in your work desk or a locker at school for a quick brushing ...
(Date:5/27/2017)... (PRWEB) , ... May 27, 2017 , ... Most us ... concern, but a new study from the Osteoarthritis Initiative shows that certain ... knee osteoarthritis. Knowing this in advance may give doctors the opportunity to treat patients ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... CEO 2017 on May 30th and 31st at The Four Seasons Hotel Boston. ... executives in the life sciences, offering exclusive access to key decision makers who ...
Breaking Medicine News(10 mins):